Literature DB >> 14580961

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.

Simon L Croft1, Graham H Coombs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580961     DOI: 10.1016/j.pt.2003.09.008

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


× No keyword cloud information.
  199 in total

1.  In silico work flow for scaffold hopping in Leishmania.

Authors:  Barnali Waugh; Ambarnil Ghosh; Dhananjay Bhattacharyya; Nanda Ghoshal; Rahul Banerjee
Journal:  BMC Res Notes       Date:  2014-11-17

2.  Leishmanicidal and antitumoral activities of endophytic fungi associated with the Antarctic angiosperms Deschampsia antarctica Desv. and Colobanthus quitensis (Kunth) Bartl.

Authors:  Iara F Santiago; Tânia M A Alves; Ana Rabello; Policarpo A Sales Junior; Alvaro J Romanha; Carlos L Zani; Carlos A Rosa; Luiz H Rosa
Journal:  Extremophiles       Date:  2011-11-10       Impact factor: 2.395

3.  Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl-hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin B.

Authors:  Maryam Iman; Zhaohua Huang; Francis C Szoka; Mahmoud R Jaafari
Journal:  Int J Pharm       Date:  2011-01-26       Impact factor: 5.875

4.  Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1.

Authors:  Helen Denton; Joanne C McGregor; Graham H Coombs
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

5.  Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.

Authors:  Marta Gontijo Aguiar; Aline Márcia Machado Pereira; Ana Paula Fernandes; Lucas Antonio Miranda Ferreira
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

6.  Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.

Authors:  Salvador Iborra; Javier Carrión; Charles Anderson; Carlos Alonso; David Sacks; Manuel Soto
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

7.  Probing the structure of Leishmania donovani chagasi DHFR-TS: comparative protein modeling and protein-ligand interaction studies.

Authors:  Lakshmi Maganti; Prabu Manoharan; Nanda Ghoshal
Journal:  J Mol Model       Date:  2010-02-21       Impact factor: 1.810

8.  Leishmanicidal activity of two naphthoquinones against Leishmania donovani.

Authors:  Claudio Manuel Lezama-Dávila; Angelica Patricia Isaac-Márquez; Govind Kapadia; Katherine Owens; Steve Oghumu; Stephen Beverley; Abhay Rajaninath Satoskar
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

9.  The new pyrazolyltetrazole derivative MSN20 is effective via oral delivery against cutaneous leishmaniasis.

Authors:  Viviane Dos Santos Faiões; Maurício Silva Dos Santos; Alice Maria Rolim Bernardino; Edézio Ferreira Cunha-Júnior; Marilene Marcuzzo do Canto Cavalheiro; Eduardo Caio Torres-Santos
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

10.  Antileishmanial activity in vitro and in vivo of constituents of sea cucumber Actinopyga lecanora.

Authors:  Nasib Singh; Rajesh Kumar; Swati Gupta; Anuradha Dube; V Lakshmi
Journal:  Parasitol Res       Date:  2008-05-02       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.